Skip to main navigation Skip to search Skip to main content

Induction of labour at term with oral misoprostol versus a Foley catheter (PROBAAT-II): A multicentre randomised controlled non-inferiority trial

  • Mieke L G ten Eikelder*
  • , Katrien Oude Rengerink
  • , Marta Jozwiak
  • , Jan W. de Leeuw
  • , Irene M. de Graaf
  • , Mariëlle G. van Pampus
  • , Marloes Holswilder
  • , Martijn A. Oudijk
  • , Gert Jan van Baaren
  • , Paula J M Pernet
  • , Caroline Bax
  • , Gijs A. van Unnik
  • , Gratia Martens
  • , Martina Porath
  • , Huib van Vliet
  • , Robbert J P Rijnders
  • , A. Hanneke Feitsma
  • , Frans J M E Roumen
  • , Aren J. van Loon
  • , Hans Versendaal
  • Martin J N Weinans, Mallory Woiski, Erik van Beek, Brenda Hermsen, Ben Willem Mol, Kitty W M Bloemenkamp
*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

BACKGROUND: Labour is induced in 20-30% of all pregnancies. In women with an unfavourable cervix, both oral misoprostol and Foley catheter are equally effective compared with dinoprostone in establishing vaginal birth, but each has a better safety profile. We did a trial to directly compare oral misoprostol with Foley catheter alone.

METHODS: We did an open-label randomised non-inferiority trial in 29 hospitals in the Netherlands. Women with a term singleton pregnancy in cephalic presentation, an unfavourable cervix, intact membranes, and without a previous caesarean section who were scheduled for induction of labour were randomly allocated to cervical ripening with 50 μg oral misoprostol once every 4 h or to a 30 mL transcervical Foley catheter. The primary outcome was a composite of asphyxia (pH ≤7·05 or 5-min Apgar score <7) or post-partum haemorrhage (≥1000 mL). The non-inferiority margin was 5%. The trial is registered with the Netherlands Trial Register, NTR3466.

FINDINGS: Between July, 2012, and October, 2013, we randomly assigned 932 women to oral misoprostol and 927 women to Foley catheter. The composite primary outcome occurred in 113 (12·2%) of 924 participants in the misoprostol group versus 106 (11·5%) of 921 in the Foley catheter group (adjusted relative risk 1·06, 90% CI 0·86-1·31). Caesarean section occurred in 155 (16·8%) women versus 185 (20·1%; relative risk 0·84, 95% CI 0·69-1·02, p=0·067). 27 adverse events were reported in the misoprostol group versus 25 in the Foley catheter group. None were directly related to the study procedure.

INTERPRETATION: In women with an unfavourable cervix at term, induction of labour with oral misoprostol and Foley catheter has similar safety and effectiveness.

FUNDING: FondsNutsOhra.

Original languageEnglish
Pages (from-to)1619–1628
JournalThe Lancet
Volume387
Issue number10028
DOIs
Publication statusPublished - Apr 2016

Fingerprint

Dive into the research topics of 'Induction of labour at term with oral misoprostol versus a Foley catheter (PROBAAT-II): A multicentre randomised controlled non-inferiority trial'. Together they form a unique fingerprint.

Cite this